Aurora Cannabis Inc. (ACB) has reported its fourth-quarter earnings, revealing a shortfall compared to analysts\u2019 expectations. The company recorded earnings of $0.07 per share for the quarter ending March 2025, falling short of the Zacks Consensus Estimate of $0.11 per share. This represents a decline from the earnings of $0.11 per share reported in the same quarter last year. The earnings miss translates to a surprise of -36.36%.<\/p>\n\n\n\n
In the previous quarter, Aurora Cannabis had exceeded expectations, posting earnings of $0.06 per share against an estimated $0.04, resulting in a positive surprise of 50%. Over the last year, Aurora has surpassed consensus earnings per share (EPS) estimates three out of four times.<\/p>\n\n\n\n
In terms of revenue, Aurora Cannabis generated $63.07 million for the same quarter, exceeding the Zacks Consensus Estimate by 1.65%. This figure marks a substantial increase from the $49.98 million in revenue reported during the same quarter last year. The company has consistently outperformed revenue expectations, achieving this in all four of the previous quarters.<\/p>\n\n\n\n
The performance of Aurora Cannabis shares has been noteworthy, showing an increase of approximately 38.4% since the start of the year, while the S&P 500 has gained only 1.7%. This growth raises questions about the stock’s future trajectory, particularly after the recent earnings report.<\/p>\n\n\n\n
Investors are keen to see how the earnings outlook will evolve, especially as it pertains to the upcoming quarters. Current consensus estimates predict an EPS of $0.17 on revenues of $69.13 million for the next quarter and $0.44 on revenues of $268.33 million for the current fiscal year.<\/p>\n\n\n\n
The company’s management’s commentary during the earnings call will be crucial in shaping investor sentiment and expectations. The trends in earnings estimate revisions leading up to the earnings release have been mixed, resulting in a Zacks Rank of #3 (Hold) for the stock, indicating that it is expected to perform in line with the market in the near term.<\/p>\n\n\n\n
As Aurora Cannabis continues to navigate its financial landscape, future estimates and revisions will play a key role in determining the stock’s movement and investor confidence.<\/p>","protected":false},"excerpt":{"rendered":"
Aurora Cannabis Inc. (ACB) ha informado de sus ganancias del cuarto trimestre, revelando un d\u00e9ficit en comparaci\u00f3n con las expectativas de los analistas. La empresa registr\u00f3 ganancias...<\/p>","protected":false},"author":2,"featured_media":8494,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46],"tags":[823,2295,1854,74,2522],"class_list":["post-8495","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry","tag-aurora-cannabis","tag-earnings","tag-financials","tag-revenue","tag-stock-market"],"yoast_head":"\n